Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-Day vs 5-Day Terlipressin and Ceftriaxone for Variceal Hemorrhage
NCT04056806Phase 4Unknown
- Sponsor
- E-Da Hospital
- Start
- Aug 2019
- Primary completion
- Jun 2022
- Modality
- Peptides, Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of terlipressin, ceftriaxone in Esophageal variceal hemorrhage (EVH), sponsored by E-Da Hospital. Status: unknown.
02
Drugs
terlipressinceftriaxone
03
Conditions
Esophageal variceal hemorrhage (EVH)
Beyond the preview
Go deeper on NCT04056806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04056806.